NSG 555 MIDTERM EXAM 2026 BANK
CURRENTLY TESTING COMPLETE
ACTUAL EXAM QUESTIONS WITH
DETAILED VERIFIED ANSWERS
EXPERT VERIFIED /ALREADY GRADED
A+
What is the main difference between dry and wet age-
related macular degeneration? - ....ANSWER...Dry is
gradual and progressive due to atrophy, while wet involves
rapid vision loss due to choroidal new vessel growth.
What are common risk factors for age-related macular
degeneration? - ....ANSWER...Aging, smoking,
genetics/family history, and low antioxidant diet.
What treatments are available for dry age-related macular
degeneration? - ....ANSWER...Pegcetacoplan and
avacincaptad pegol.
What treatments are available for wet age-related macular
degeneration? - ....ANSWER...Inhibitors of vascular
,endothelial growth factors such as ranibizumab,
bevacizumab, aflibercept, faricimab, and prolucizumab.
What is the leading cause of irreversible central vision loss
in developing countries? - ....ANSWER...Age-related
macular degeneration.
What is the primary difference between cataracts and
macular degeneration? - ....ANSWER...Cataracts affect the
lens and vision loss is reversible with surgery; macular
degeneration affects central vision and is not reversible.
What are the differences in onset between asthma and
COPD? - ....ANSWER...Asthma typically begins in
childhood/adolescence, while COPD usually occurs in adults
over 40.
How do symptoms differ between asthma and COPD? -
....ANSWER...Asthma symptoms are episodic, whereas
COPD symptoms are constant and progressive.
What is the first line treatment for asthma compared to
COPD? - ....ANSWER...Asthma is treated with inhaled
,corticosteroids (ICS), while COPD is managed with
bronchodilators.
What associated conditions are linked to asthma and
COPD? - ....ANSWER...Asthma is associated with eczema
and allergies; COPD is associated with smoking.
How is asthma diagnosed? - ....ANSWER...Through a
history of variable symptoms (wheeze, shortness of breath,
chest tightness, cough) and spirometry showing significant
improvement after bronchodilator use.
How does the post-bronchodilation response in asthma
differ from COPD? - ....ANSWER...In asthma, the post-
bronchodilation response is usually marked, while COPD
shows little change.
What is the recommended medication for asthma
symptoms less than 4-5 days a week? -
....ANSWER...Low-dose ICS-formoterol as-needed.
What treatment is suggested for asthma symptoms
occurring most days or waking with asthma once a week? -
, ....ANSWER...Low-dose maintenance ICS-formoterol and
low-dose ICS-formoterol reliever.
What is the treatment for asthma with daily symptoms or
low lung function? - ....ANSWER...Medium-dose
maintenance ICS-formoterol and low-dose ICS-formoterol
reliever.
What additional treatment is recommended for severe
asthma cases? - ....ANSWER...Add-on LAMA and consider
referral for phenotype assessment; may include high-dose
ICS-formoterol and biologics like anti-IgE, anti-IL5/5R,
anti-ILRx, or anti-TSLP.
When should oral corticosteroids be considered for asthma
patients? - ....ANSWER...In Steps 4 and 5, for patients
presenting with severely uncontrolled asthma.
What are the indications for prescribing oral
corticosteroids in asthma management? -
....ANSWER...Worsening symptoms not responding to
increased reliever or ICS for 2-3 days, rapid deterioration, or
FEV1/PEF <60% normal.
CURRENTLY TESTING COMPLETE
ACTUAL EXAM QUESTIONS WITH
DETAILED VERIFIED ANSWERS
EXPERT VERIFIED /ALREADY GRADED
A+
What is the main difference between dry and wet age-
related macular degeneration? - ....ANSWER...Dry is
gradual and progressive due to atrophy, while wet involves
rapid vision loss due to choroidal new vessel growth.
What are common risk factors for age-related macular
degeneration? - ....ANSWER...Aging, smoking,
genetics/family history, and low antioxidant diet.
What treatments are available for dry age-related macular
degeneration? - ....ANSWER...Pegcetacoplan and
avacincaptad pegol.
What treatments are available for wet age-related macular
degeneration? - ....ANSWER...Inhibitors of vascular
,endothelial growth factors such as ranibizumab,
bevacizumab, aflibercept, faricimab, and prolucizumab.
What is the leading cause of irreversible central vision loss
in developing countries? - ....ANSWER...Age-related
macular degeneration.
What is the primary difference between cataracts and
macular degeneration? - ....ANSWER...Cataracts affect the
lens and vision loss is reversible with surgery; macular
degeneration affects central vision and is not reversible.
What are the differences in onset between asthma and
COPD? - ....ANSWER...Asthma typically begins in
childhood/adolescence, while COPD usually occurs in adults
over 40.
How do symptoms differ between asthma and COPD? -
....ANSWER...Asthma symptoms are episodic, whereas
COPD symptoms are constant and progressive.
What is the first line treatment for asthma compared to
COPD? - ....ANSWER...Asthma is treated with inhaled
,corticosteroids (ICS), while COPD is managed with
bronchodilators.
What associated conditions are linked to asthma and
COPD? - ....ANSWER...Asthma is associated with eczema
and allergies; COPD is associated with smoking.
How is asthma diagnosed? - ....ANSWER...Through a
history of variable symptoms (wheeze, shortness of breath,
chest tightness, cough) and spirometry showing significant
improvement after bronchodilator use.
How does the post-bronchodilation response in asthma
differ from COPD? - ....ANSWER...In asthma, the post-
bronchodilation response is usually marked, while COPD
shows little change.
What is the recommended medication for asthma
symptoms less than 4-5 days a week? -
....ANSWER...Low-dose ICS-formoterol as-needed.
What treatment is suggested for asthma symptoms
occurring most days or waking with asthma once a week? -
, ....ANSWER...Low-dose maintenance ICS-formoterol and
low-dose ICS-formoterol reliever.
What is the treatment for asthma with daily symptoms or
low lung function? - ....ANSWER...Medium-dose
maintenance ICS-formoterol and low-dose ICS-formoterol
reliever.
What additional treatment is recommended for severe
asthma cases? - ....ANSWER...Add-on LAMA and consider
referral for phenotype assessment; may include high-dose
ICS-formoterol and biologics like anti-IgE, anti-IL5/5R,
anti-ILRx, or anti-TSLP.
When should oral corticosteroids be considered for asthma
patients? - ....ANSWER...In Steps 4 and 5, for patients
presenting with severely uncontrolled asthma.
What are the indications for prescribing oral
corticosteroids in asthma management? -
....ANSWER...Worsening symptoms not responding to
increased reliever or ICS for 2-3 days, rapid deterioration, or
FEV1/PEF <60% normal.
